| Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals |  | | 2023 | 72 | 65 |
|
| Physiologically-based pharmacokinetic modeling for the prediction of CYP2D6-mediated gene-drug-drug interactions | CPT: pharmacometrics & systems pharmacology | | | 2019 | 416 | 588 |
|
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | | | 2018 | 526 | 1,113 |
|
| Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomes | Basic & Clinical Pharmacology & Toxicology | | | 2018 | 518 | 1,071 |
|
| Understanding and predicting the association of intrinsic and extrinsic factors of pharmacokinetic variability in the context of precision medicine: impact of genetic polymorphisms on CYP2D6-mediated drug-drug interactions | |  | | 2018 | 874 | 35 |
|
| Impact of CYP2D6 functional allelic variations on phenoconversion and drug-drug interactions | Clinical Pharmacology and Therapeutics | | | 2017 | 501 | 5 |
|
| The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation | Frontiers in Pharmacology | | | 2017 | 624 | 285 |
|
| Pharmacogenomics of Oral Antithrombotic Drugs | Current pharmaceutical design | | | 2016 | 628 | 0 |
|
| The effect of proton pump inhibitors on platelet activity: An ex-vivo study | | | | 2012 | 315 | 18 |
|
